HomeBDX • NYSE
add
Becton Dickinson and Co
Previous close
$225.45
Day range
$223.13 - $226.24
Year range
$218.75 - $249.89
Market cap
64.75B USD
Avg Volume
1.44M
P/E ratio
37.77
Dividend yield
1.86%
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 5.44B | 6.88% |
Operating expense | 1.69B | 39.47% |
Net income | 421.00M | 289.81% |
Net profit margin | 7.74 | 265.09% |
Earnings per share | 3.81 | 11.40% |
EBITDA | 1.39B | -15.00% |
Effective tax rate | 22.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.16B | 51.83% |
Total assets | 57.29B | 8.54% |
Total liabilities | 31.38B | 16.27% |
Total equity | 25.91B | — |
Shares outstanding | 289.61M | — |
Price to book | 2.52 | — |
Return on assets | 3.66% | — |
Return on capital | 4.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 421.00M | 289.81% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. Wikipedia
CEO
Founded
1897
Headquarters
Website
Employees
70,000
